This study by Mautner et al. compared the clinical efficacy of Microfragmented Adipose Tissue (MFAT) versus Bone Marrow Aspirate Concentrate (BMAC) injections for symptomatic knee osteoarthritis. Analyzing 76 patients over a mean follow-up of 1 to 1.8 years, the researchers found that both treatments yielded statistically significant improvements in pain, function, and quality of life (p < .001). Crucially, there was no significant difference in outcomes between the two tissue sources, suggesting that MFAT and BMAC are equally effective orthobiologic options. While lower-grade osteoarthritis (KL Grades 1 and 2) showed the highest responder rates, even more advanced cases (KL Grade 4) demonstrated over a 50% response rate, indicating that both autologous sources provide a durable alternative to traditional conservative therapies.